Foxo Technologies Inc
OTC:FOXO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mainz Biomed NV
NASDAQ:QUCY
|
DE |
Foxo Technologies Inc
Research & Development
Foxo Technologies Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Foxo Technologies Inc
OTC:FOXO
|
Research & Development
-$312.3k
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Salesforce Inc
NYSE:CRM
|
Research & Development
-$6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-20%
|
|
|
Palantir Technologies Inc
NASDAQ:PLTR
|
Research & Development
-$557.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Applovin Corp
NASDAQ:APP
|
Research & Development
-$226.5m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Intuit Inc
NASDAQ:INTU
|
Research & Development
-$3.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-15%
|
|
|
Adobe Inc
NASDAQ:ADBE
|
Research & Development
-$4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-17%
|
|
Foxo Technologies Inc
Glance View
FOXO Technologies, Inc. develops genetic sequencing technology artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota and currently employs 24 full-time employees. The company went IPO on 2020-12-11. The firm is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The firm operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.
See Also
What is Foxo Technologies Inc's Research & Development?
Research & Development
-312.3k
USD
Based on the financial report for Dec 31, 2024, Foxo Technologies Inc's Research & Development amounts to -312.3k USD.
What is Foxo Technologies Inc's Research & Development growth rate?
Research & Development CAGR 3Y
60%
Over the last year, the Research & Development growth was 65%. The average annual Research & Development growth rates for Foxo Technologies Inc have been 60% over the past three years .
